MetaCap

Teva Pharmaceutical Industries Statistics

NYSE: TEVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

39.23+0.69 (+1.79%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Teva Pharmaceutical Industries by the numbers

Teva Pharmaceutical Industries has a market capitalization of $45.77 billion based on 1.17B shares outstanding. Its trailing P/E ratio is 91.2, above the 5-company peer median of 43.2, and its forward P/E is 12.5. The stock trades 3.4% below its 50-day average and 11.3% above its 200-day average.

Average daily trading volume is 6.31M shares, or about $247.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TEVA valuation vs. peer median

TEVA compared with the median of 8 peer companies
MetricTEVAPeer medianDifference
Market cap$45.77B$31.10B+47%
P/E (TTM)91.243.2+111%
Forward P/E12.517.4-28%
Avg. volume6.31M3.70M+71%

Peer median across 8 companies: ONC, RPRX, ZTS, GMAB, INSM, ROIV, UTHR, VTRS.

Valuation

Market cap
$45.77B
Price / sales (latest FY)
2.65

Price and trading

Previous close
38.54
Open
38.46
Day range
38.30 – 39.91
52-week range
24.34 – 44.57
52-week change
+62.04%
Beta
—
Volume
6.81M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
45.77B
Pe
91.23
Forward Pe
12.53
Eps
0.43
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
44.57
Week52 Low
24.34
Avg Volume
6.31M
Shares Outstanding
1.17B
Ma50
40.62
Ma200
35.25
Earnings Date
Nov 3, 2026
Pct From52w High
-11.98%
Pct From52w Low
61.18%

Related